Market Overview

Oppenheimer Initiates Coverage on Quest Diagnostics Incorporated at Underperform, Announces $53.00 undefined

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for DGX

DateFirmActionFromTo
Oct 2015BarclaysMaintainsEqualweight
Aug 2015Canaccord GenuityMaintainsBuy
Jun 2015Goldman SachsDowngradesBuyNeutral

View More Analyst Ratings for DGX
View the Latest Analyst Ratings

Posted-In: News Analyst Ratings

 

Related Articles (DGX)

Get Benzinga's Newsletters